-
1
-
-
69949085340
-
A reassessment of risks and benefits of dopamine agonists in Parkinson's disease
-
Antonini A, Tolosa E, Mizuno Y, Yamamoto M, and Poewe WH (2009) A reassessment of risks and benefits of dopamine agonists in Parkinson's disease. Lancet Neurol 8:929-937.
-
(2009)
Lancet Neurol
, vol.8
, pp. 929-937
-
-
Antonini, A.1
Tolosa, E.2
Mizuno, Y.3
Yamamoto, M.4
Poewe, W.H.5
-
2
-
-
0024368819
-
Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation
-
Bond RA, Ornstein AG, and Clarke DE (1989) Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation. J Pharmacol Exp Ther 249:401-410. (Pubitemid 19144827)
-
(1989)
Journal of Pharmacology and Experimental Therapeutics
, vol.249
, Issue.2
, pp. 401-410
-
-
Bond, R.A.1
Ornstein, A.G.2
Clarke, D.E.3
-
3
-
-
0030903068
-
RS-102221: A novel high affinity and selective, 5-HT(2C) receptor antagonist
-
DOI 10.1016/S0028-3908(97)00049-X, PII S002839089700049X
-
Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, et al. (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621-629. (Pubitemid 27272107)
-
(1997)
Neuropharmacology
, vol.36
, Issue.4-5
, pp. 621-629
-
-
Bonhaus, D.W.1
Weinhardt, K.K.2
Taylor, M.3
Desouza, A.4
Mcneeley, P.M.5
Szczepanski, K.6
Fontana, D.J.7
Trinh, J.8
Rocha, C.L.9
Dawson, M.W.10
Flippin, L.A.11
Eglen, R.M.12
-
4
-
-
0030028272
-
The role of thrombosis in severe pulmonary hypertension
-
DOI 10.1183/09031936.96.09020356
-
Chaouat A, Weitzenblum E, and Higenbottam T (1996) The role of thrombosis in severe pulmonary hypertension. Eur Respir J 9:356-363. (Pubitemid 26068632)
-
(1996)
European Respiratory Journal
, vol.9
, Issue.2
, pp. 356-363
-
-
Chaouat, A.1
Weitzenblum, E.2
Higenbottam, T.3
-
5
-
-
85047694529
-
Disorders of lung matrix remodeling
-
Chapman HA (2004) Disorders of lung matrix remodeling. J Clin Invest 113:148-157.
-
(2004)
J Clin Invest
, vol.113
, pp. 148-157
-
-
Chapman, H.A.1
-
6
-
-
70349238724
-
Fenfluramine disrupts the mitral valve interstitial cell response to serotonin
-
Connolly JM, Bakay MA, Fulmer JT, Gorman RC, Gorman JH 3rd, Oyama MA, and Levy RJ (2009) Fenfluramine disrupts the mitral valve interstitial cell response to serotonin. Am J Pathol 175:988-997.
-
(2009)
Am J Pathol
, vol.175
, pp. 988-997
-
-
Connolly, J.M.1
Bakay, M.A.2
Fulmer, J.T.3
Gorman, R.C.4
Gorman III, J.H.5
Oyama, M.A.6
Levy, R.J.7
-
7
-
-
79956122627
-
Platelet-derived serotonin links vascular disease and tissue fibrosis
-
Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, Jüngel A, Beyer C, Krönke G, Zwerina J, et al. (2011) Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 208:961-972.
-
(2011)
J Exp Med
, vol.208
, pp. 961-972
-
-
Dees, C.1
Akhmetshina, A.2
Zerr, P.3
Reich, N.4
Palumbo, K.5
Horn, A.6
Jüngel, A.7
Beyer, C.8
Krönke, G.9
Zwerina, J.10
-
8
-
-
66949173351
-
Cyproheptadine prevents pergolide-induced valvulopathy in rats: An echocardiographic and histopathological study
-
Droogmans S, Roosens B, Cosyns B, Degaillier C, Hernot S, Weytjens C, Garbar C, Caveliers V, Pipeleers-Marichal M, Franken PR, et al. (2009) Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study. Am J Physiol Heart Circ Physiol 296:H1940-H1948.
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.296
-
-
Droogmans, S.1
Roosens, B.2
Cosyns, B.3
Degaillier, C.4
Hernot, S.5
Weytjens, C.6
Garbar, C.7
Caveliers, V.8
Pipeleers-Marichal, M.9
Franken, P.R.10
-
9
-
-
79955663912
-
Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats
-
Dumitrascu R, Kulcke C, Königshoff M, Kouri F, Yang X, Morrell N, Ghofrani HA, Weissmann N, Reiter R, Seeger W, et al. (2011) Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats. Eur Respir J 37:1104-1118.
-
(2011)
Eur Respir J
, vol.37
, pp. 1104-1118
-
-
Dumitrascu, R.1
Kulcke, C.2
Königshoff, M.3
Kouri, F.4
Yang, X.5
Morrell, N.6
Ghofrani, H.A.7
Weissmann, N.8
Reiter, R.9
Seeger, W.10
-
10
-
-
56149102469
-
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
-
Fabre A, Marchal-Sommé J, Marchand-Adam S, Quesnel C, Borie R, Dehoux M, Ruffié C, Callebert J, Launay JM, Hénin D, et al. (2008) Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Eur Respir J 32:426-436.
-
(2008)
Eur Respir J
, vol.32
, pp. 426-436
-
-
Fabre, A.1
Marchal-Sommé, J.2
Marchand-Adam, S.3
Quesnel, C.4
Borie, R.5
Dehoux, M.6
Ruffié, C.7
Callebert, J.8
Launay, J.M.9
Hénin, D.10
-
11
-
-
0021240047
-
Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents
-
Glusa E and Markwardt F (1984) Inhibition of 5-hydroxytryptamine- potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents. Biomed Biochim Acta 43:215-220. (Pubitemid 14130737)
-
(1984)
Biomedica Biochimica Acta
, vol.43
, Issue.2
, pp. 215-220
-
-
Glusa, E.1
Markwardt, F.2
-
12
-
-
0034068805
-
Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors
-
Glusa E and Pertz HH (2000) Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors. Br J Pharmacol 130:692-698. (Pubitemid 30332990)
-
(2000)
British Journal of Pharmacology
, vol.130
, Issue.3
, pp. 692-698
-
-
Glusa, E.1
Pertz, H.H.2
-
13
-
-
40849124264
-
2A receptors
-
DOI 10.1124/jpet.107.133165
-
Görnemann T, Hübner H, Gmeiner P, Horowski R, Latté KP, Flieger M, and Pertz HH (2008) Characterization of the molecular fragment that is responsible for agonism of pergolide at serotonin 5-hydroxytryptamine 2B and 5-hydroxytryptamine 2A receptors. J Pharmacol Exp Ther 324:1136-1145. (Pubitemid 351397829)
-
(2008)
Journal of Pharmacology and Experimental Therapeutics
, vol.324
, Issue.3
, pp. 1136-1145
-
-
Gornemann, T.1
Hubner, H.2
Gmeiner, P.3
Horowski, R.4
Latte, K.P.5
Flieger, M.6
Pertz, H.H.7
-
15
-
-
34547687436
-
Long-term serotonin effects in the rat are prevented by terguride
-
DOI 10.1016/j.regpep.2007.02.009, PII S0167011507000547
-
Hauso Ø, Gustafsson BI, Loennechen JP, Stunes AK, Nordrum I, and Waldum HL (2007) Long-term serotonin effects in the rat are prevented by terguride. Regul Pept 143:39-46. (Pubitemid 47212520)
-
(2007)
Regulatory Peptides
, vol.143
, Issue.1-3
, pp. 39-46
-
-
Hauso, O.1
Gustafsson, B.I.2
Loennechen, J.P.3
Stunes, A.K.4
Nordrum, I.5
Waldum, H.L.6
-
19
-
-
0025543036
-
Ketanserin prevents early restenosis following percutaneous transluminal coronary angioplasty
-
Klein W, Eber B, Dusleag J, Rotman B, Költringer P, Luha O, and Vanhoutte PM (1990) Ketanserin prevents early restenosis following percutaneous transluminal coronary angioplasty. Clin Physiol Biochem 8 (Suppl 3):101-107.
-
(1990)
Clin Physiol Biochem
, vol.8
, Issue.SUPPL. 3
, pp. 101-107
-
-
Klein, W.1
Eber, B.2
Dusleag, J.3
Rotman, B.4
Költringer, P.5
Luha, O.6
Vanhoutte, P.M.7
-
21
-
-
78149303247
-
Increased expression of 5-hydroxytryptamine 2A/B receptors in idiopathic pulmonary fibrosis: A rationale for therapeutic intervention
-
Königshoff M, Dumitrascu R, Udalov S, Amarie OV, Reiter R, Grimminger F, Seeger W, Schermuly RT, and Eickelberg O (2010) Increased expression of 5-hydroxytryptamine 2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. Thorax 65:949-955.
-
(2010)
Thorax
, vol.65
, pp. 949-955
-
-
Königshoff, M.1
Dumitrascu, R.2
Udalov, S.3
Amarie, O.V.4
Reiter, R.5
Grimminger, F.6
Seeger, W.7
Schermuly, R.T.8
Eickelberg, O.9
-
22
-
-
1542346060
-
2A Receptors of Rat Tail Artery
-
Kren V, Eich E, and Pertz HH (2004) Pergolide, terguride and N,N′-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery. Physiol Res 53:35-43. (Pubitemid 38295539)
-
(2004)
Physiological Research
, vol.53
, Issue.1
, pp. 35-43
-
-
Kren, V.1
Eich, E.2
Pertz, H.H.3
-
23
-
-
0036799278
-
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
-
DOI 10.1038/nm764
-
Launay JM, Hervé P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, et al. (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8:1129-1135. (Pubitemid 35175968)
-
(2002)
Nature Medicine
, vol.8
, Issue.10
, pp. 1129-1135
-
-
Launay, J.-M.1
Herve, P.2
Peoc'h, K.3
Tournois, C.4
Callebert, J.5
Nebigil, C.G.6
Etienne, N.7
Drouet, L.8
Humbert, M.9
Simonneau, G.10
Maroteaux, L.11
-
24
-
-
33644865941
-
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice
-
DOI 10.1161/CIRCULATIONAHA.105.554667, PII 0000301720060103000014
-
Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, Lanfumey L, Seif I, Benhaiem-Sigaux N, Kirsch M, Hamon M, et al. (2006) Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 113:81-89. (Pubitemid 43958492)
-
(2006)
Circulation
, vol.113
, Issue.1
, pp. 81-89
-
-
Mekontso-Dessap, A.1
Brouri, F.2
Pascal, O.3
Lechat, P.4
Hanoun, N.5
Lanfumey, L.6
Seif, I.7
Benhaiem-Sigaux, N.8
Kirsch, M.9
Hamon, M.10
Adnot, S.11
Eddahibi, S.12
-
25
-
-
0027438970
-
2 receptor: Structurally specific differentiation by ergolines and tryptamines
-
Nelson DL, Lucaites VL, Audia JE, Nissen JS, and Wainscott DB (1993) Species differences in the pharmacology of the 5-hydroxytryptamine 2 receptor: structurally specific differentiation by ergolines and tryptamines. J Pharmacol Exp Ther 265:1272-1279. (Pubitemid 23321030)
-
(1993)
Journal of Pharmacology and Experimental Therapeutics
, vol.265
, Issue.3
, pp. 1272-1279
-
-
Nelson, D.L.1
Lucaites, V.L.2
Audia, J.E.3
Nissen, J.S.4
Wainscott, D.B.5
-
27
-
-
0036828154
-
2, receptor subtypes
-
DOI 10.1124/jpet.102.039883
-
Newman-Tancredi A, Cussac D, Quentric Y, Touzard M, Verrièle L, Carpentier N, and Millan MJ (2002b) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT1 and 5-HT2, receptor subtypes. J Pharmacol Exp Ther 303:815-822. (Pubitemid 35231258)
-
(2002)
Journal of Pharmacology and Experimental Therapeutics
, vol.303
, Issue.2
, pp. 815-822
-
-
Newman-Tancredi, A.1
Cussac, D.2
Quentric, Y.3
Touzard, M.4
Verriele, L.5
Carpentier, N.6
Millan, M.J.7
-
28
-
-
33644872570
-
Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery
-
Nishihira K, Yamashita A, Tanaka N, Kawamoto R, Imamura T, Yamamoto R, Eto T, and Asada Y (2006) Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery. J Thromb Haemost 4:247-255.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 247-255
-
-
Nishihira, K.1
Yamashita, A.2
Tanaka, N.3
Kawamoto, R.4
Imamura, T.5
Yamamoto, R.6
Eto, T.7
Asada, Y.8
-
29
-
-
0026510533
-
2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition
-
2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition. Naunyn-Schmiedebergs Arch Pharmacol 345:394-401.
-
(1992)
Naunyn-Schmiedebergs Arch Pharmacol
, vol.345
, pp. 394-401
-
-
Pertz, H.1
Eich, E.2
-
30
-
-
33846017361
-
Drugs and valvular heart disease
-
Roth BL (2007) Drugs and valvular heart disease. N Engl J Med 356:6-9.
-
(2007)
N Engl J Med
, vol.356
, pp. 6-9
-
-
Roth, B.L.1
-
32
-
-
33748798900
-
A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis
-
DOI 10.2353/ajpath.2006.050767
-
Ruddell RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, and Mann DA (2006) A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 169:861-876. (Pubitemid 44411953)
-
(2006)
American Journal of Pathology
, vol.169
, Issue.3
, pp. 861-876
-
-
Ruddell, R.G.1
Oakley, F.2
Hussain, Z.3
Yeung, I.4
Bryan-Lluka, L.J.5
Ramm, G.A.6
Mann, D.A.7
-
33
-
-
0001119608
-
Serotonin receptors. Signal transduction pathways
-
Bloom FE and Kupfer DJ eds Raven Press, New York
-
Sanders-Bush E and Canton H (1995) Serotonin receptors. Signal transduction pathways, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 431-441, Raven Press, New York.
-
(1995)
Psychopharmacology: The Fourth Generation of Progress
, pp. 431-441
-
-
Sanders-Bush, E.1
Canton, H.2
-
34
-
-
0038779278
-
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro
-
DOI 10.1124/mol.63.6.1223
-
Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, and Roth BL (2003) 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 63:1223-1229. (Pubitemid 36627216)
-
(2003)
Molecular Pharmacology
, vol.63
, Issue.6
, pp. 1223-1229
-
-
Setola, V.1
Hufeisen, S.J.2
Grande-Allen, K.J.3
Vesely, I.4
Glennon, R.A.5
Blough, B.6
Rothman, R.B.7
Roth, B.L.8
-
35
-
-
0031718736
-
Primary pulmonary hypertension associated with the use of fenfluramine derivatives
-
Simonneau G, Fartoukh M, Sitbon O, Humbert M, Jagot JL, and Hervé P (1998) Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest 114:195S-199S. (Pubitemid 28435967)
-
(1998)
Chest
, vol.114
, Issue.3 SUPPL.
-
-
Simonneau, G.1
Fartoukh, M.2
Sitbon, O.3
Humbert, M.4
Jagot, J.-L.5
Herve, P.6
-
36
-
-
70849103411
-
Mechanism of action of trazodone: A multifunctional drug
-
Stahl SM (2009) Mechanism of action of trazodone: a multifunctional drug. CNS Spectr 14:536-546.
-
(2009)
CNS Spectr
, vol.14
, pp. 536-546
-
-
Stahl, S.M.1
-
37
-
-
0033872052
-
The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system
-
Swaisgood CM, French EL, Noga C, Simon RH, and Ploplis VA (2000) The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157:177-187. (Pubitemid 30641735)
-
(2000)
American Journal of Pathology
, vol.157
, Issue.1
, pp. 177-187
-
-
Swaisgood, C.M.1
French, E.L.2
Noga, C.3
Simon, R.H.4
Ploplis, V.A.5
-
38
-
-
0029156503
-
Expression of serotonin receptor mRNAs in blood vessels
-
Ullmer C, Schmuck K, Kalkman HO, and Lübbert H (1995) Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370:215-221.
-
(1995)
FEBS Lett
, vol.370
, pp. 215-221
-
-
Ullmer, C.1
Schmuck, K.2
Kalkman, H.O.3
Lübbert, H.4
-
39
-
-
73649209211
-
Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters
-
Van Rossum JM (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 143:299-330.
-
(1963)
Arch Int Pharmacodyn Ther
, vol.143
, pp. 299-330
-
-
Van Rossum, J.M.1
-
40
-
-
0036899272
-
2receptor and its signaling pathway in aortic valve interstitial cells
-
2receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol 161:2209-2218.
-
(2002)
Am J Pathol
, vol.161
, pp. 2209-2218
-
-
Xu, J.1
Jian, B.2
Chu, R.3
Lu, Z.4
Li, Q.5
Dunlop, J.6
Rosenzweig-Lipson, S.7
McGonigle, P.8
Levy, R.J.9
Liang, B.10
|